OUR MISSION

NeuEsse Inc. is an emerging regenerative medicine development company with a goal of enhancing the quality of life of consumers and patients by providing novel nano-materials for the repair and regeneration of diseased, traumatized and aging skin. Its innovative technologies are intended to revolutionize the unmet needs in multiple commercial and therapeutic applications in the Regenerative Medicine space.

Our mission is to improve patient treatment and outcomes by using a plant-based human skin substitute in either a protein material bandage or a “no-touch” application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver our skin substitutes along with other therapeutics for military and civilian patients.

OUR TEAM

Joe Headshot
Joseph P. Connell
Chief Executive Officer

Joe Connell Founder/CEO brings more than 35 years of pharmaceutical and biotechnology sales, marketing and executive management experience. His career started as a Pharmaceutical Sales representative with Roche Laboratories. He has had roles of increasing responsibility, including as COO, President and CEO, of startup and specialty pharmaceutical companies…

Bruce Headshot
Bruce D. Mullen
Chief Operating Officer

Bruce Mullen, COO brings 38+ years of focus on emerging and new technology, start-ups, at-risk and early-to-market companies, new venture opportunities and launches, nurturing customer and partner relationships. He co-founded and managed a global physician verification system startup with AMA, NHS and WHO data partners and a US subsidiary of a UK healthcare information company…

180123_PeterLelkes-22
Peter I. Lelkes
Chief Scientific Advisor

Dr. Lelkes leads the team responsible for the invention of OmegaSkin™ that utilizes soybean plant protein isolate and its unique hand-held spin blower delivery technology. He is the Laura H. Carnell Professor and Founding Chair of the Department of Bioengineering in the College of Engineering at Temple University and the Inaugural Director of the Institute for Regenerative Medicine and Engineering…